Atorvastatin cuts anthracycline heart failure

Published Date: 08 Mar 2023

Atorvastatin 40 mg daily for 12 months reduces cardiovascular events in lymphoma patients treated with anthracyclines.

Read Full News

Latest News

Is Rapid Weight Loss More Effective Than Gradual Loss?

Rapid weight loss delivered in a structured program yields better outcomes than gradual weight loss, but other factors also need to be considered.

Human Coaching Boosts Adherence in AI Wearable Obesity Study

The results suggest that hybrid models may outperform fully automated approaches.

Why Some Centenarians Maintain Younger Immune Systems

Researchers find that preserved immune signaling and key immune cells may help explain why some centenarians avoid severe diseases longer than expected.

Cardiorenal Benefits of GLP-1s Found in Type 1 Diabetes

A large database study shows lower risk for major adverse cardiovascular events and end-stage kidney disease, with no increase in adverse events.

How Lifeline Brought the AMR Crisis to the London Stage

Real doctors joined the London cast of Lifeline the Musical to bring the growing threat of antimicrobial resistance to wider audiences.

Low Natriuretic Peptide Levels in Obesity? HF Risk Persists

Adults with obesity may have natriuretic peptide levels below the usual rule-out threshold and still have increased odds of signs and symptoms of heart failure and other risks.

Todays Updates

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

Researchers are testing CAR T-cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue.

Todays Updates

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

Researchers are testing CAR T-cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue.

Latest News

Rapid weight loss delivered in a structured program yields better outcomes than gradual weight loss, but other factors also need to be considered.

The results suggest that hybrid models may outperform fully automated approaches.

Researchers find that preserved immune signaling and key immune cells may help explain why some centenarians avoid severe diseases longer than expected.

A large database study shows lower risk for major adverse cardiovascular events and end-stage kidney disease, with no increase in adverse events.

Real doctors joined the London cast of Lifeline the Musical to bring the growing threat of antimicrobial resistance to wider audiences.

Adults with obesity may have natriuretic peptide levels below the usual rule-out threshold and still have increased odds of signs and symptoms of heart failure and other risks.

News All Time

Uraemic Marker Predicts Mortality After Kidney Transplant

Plasma levels of symmetric dimethylarginine are independently associated with an increased risk for mortality in adult kidney transplant recipients, a prospective study finds.

GLP-1 Drugs Tied to Cardiovascular Benefits in T1D

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant increase in diabetic ketoacidosis compared with those who do not.

Transient Neurologic Symptoms: What Clinicians Miss

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes requiring rapid evaluation.

Orforglipron Maintains Weight Loss After Injectables

The study adds evidence that obesity treatment benefits depend on continued therapy, even when the delivery method changes.

SGLT2 Inhibitors Show Similar Cardiorenal Benefits

Empagliflozin and dapagliflozin show similar effectiveness in preventing cardiorenal outcomes among patients with type 2 diabetes without prior cardiovascular or renal disease.

Date Sweetened Foods May Create a Misleading Health Halo

Products sweetened with dates may appear healthier than table sugar, even though concentrated fructose exposure remains a concern.

Telerehabilitation May Support Stroke Recovery at Home

Remote rehabilitation programs improve mobility, balance, and quality of life after stroke, with added benefits in adherence and patient satisfaction.

Weather Extremes, Pollution May Raise Major CV Event Risk

A geography-based study in Poland found airborne pollutants can compound the cardiovascular risks of heatwaves and cold snaps, with the latter actually being more hazardous.

AI-Powered ECG Shown to Spot Heart Failure

Screening for heart failure with an AI-ECG algorithm could be particularly useful in places with limited access to more advanced diagnostics.

SCORE2, Health Dialogues for Risk Factors in Mental Illness

Patients with mental illness seeking primary care show an elevated cardiovascular risk as per SCORE2, and targeted health dialogues identify additional modifiable cardiovascular risk factors.

Electric Scooter-Related Injuries Strain Urban Trauma Units

Emergency departments in Rome and New York reported increasing fractures and head injuries linked to electric scooters and e-bikes, with helmet use remaining low.

Postpartum Hypertension Follow-Up Care Falls Short

Preeclampsia can lead to development of chronic hypertension in the decade following pregnancy.

Cruise Ship Outbreak Raises Andes Virus Spread Concerns

European health agencies are monitoring passengers and crew members after suspected hantavirus exposure raised concerns about rare human transmission patterns.

Early Physical Activity Safe After MI

Patients who started physical activity within a week of discharge for a heart attack have no greater cardiovascular risk than less active patients in a recent study.

Long Delays in Cardiac Amyloidosis Diagnosis Persist

Most older adults with transthyretin cardiac amyloidosis face a several-month delay in diagnosis after a heart failure diagnosis, despite overall increased diagnostic frequency of amyloidosis.

Preventive Care With the Most Bang for Your Buck

An analysis of USPSTF and ACIP recommendations shows wide variation in impact, helping clinicians prioritize care during time-constrained visits.

Recommended News For You

Glofitamab Regimen Improves Survival in DLBCL

Survey: Record Numbers of US Adults Report Depression.

Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US

Enhanced CAR T cell therapy offers new strategy for lymphoma

For relapsed or resistant DLBCL, odronextamab produced positive results.

Having a tattoo could increase your risk of developing lymphoma.

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

Recommended Articles For You

Everything You Need to Know About Leiomyomas: A Comprehensive Guide  

A New Hope: How Procarbazine is Revolutionizing Cancer Treatment 

7 Subtle Signs of Leukemia: How to Spot the Symptoms Early 

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Data indicate 1 in 3 US adults unaware of connection between HPV and cancers

2.

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

3.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

4.

A novel blood test may enable the early identification of common, fatal cancers.

5.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

1.

What You Need to Know About the Early Warning Signs of Colon Cancer 

2.

Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer

3.

Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells

4.

Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production

5.

Unlocking the Potential of Polatuzumab for Cancer Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part X

2.

Navigating the Complexities of Ph Negative ALL - Part XII

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

4.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot